Home > Financial Ratios > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM
Core EBITDA Growth

    Back to All Ratios
TATVA CHINTAN PHARMA CHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for TATVA CHINTAN PHARMA CHEM
Please provide your vote to see the results

TATVA CHINTAN PHARMA CHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 14.10-43.4063.5226.8663.71

What is the latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM ?

The latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM is 14.10 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202414.10
Mar2023-43.40
Mar202263.52
Mar202126.86
Mar202063.71

How is Core EBITDA Growth of TATVA CHINTAN PHARMA CHEM Trending?

Years Core EBITDA Growth % Change
Mar2024 14.1
Positive
Mar2023 -43.4
Negative
Mar2022 63.52
136.49
Mar2021 26.86
-57.84
Mar2020 63.71 -

Other Financial Ratios of TATVA CHINTAN PHARMA CHEM


Compare Core EBITDA Growth ratio of peers of TATVA CHINTAN PHARMA CHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM ₹2,385.2 Cr -4.9% -5.2% 0.7% Stock Analytics
PIDILITE INDUSTRIES ₹157,781.0 Cr -0.4% 1.6% -3.2% Stock Analytics
SOLAR INDUSTRIES INDIA ₹125,569.0 Cr -2.9% -6.9% 28.3% Stock Analytics
SRF ₹86,922.1 Cr -0.5% 1% 10.4% Stock Analytics
GODREJ INDUSTRIES ₹40,914.9 Cr 1.2% 9.4% -0.2% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹39,857.4 Cr 7.3% 1% -4.5% Stock Analytics


TATVA CHINTAN PHARMA CHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM

-4.9%

-5.2%

0.7%

SENSEX

1.2%

0.7%

-1.5%


You may also like the below Video Courses